Large gap with delayed quotes
|
Last quote
04/27/2026
-
16:34:23
|
Bid
04/27/2026 -
16:34:33
|
Bid Volume |
Ask
04/27/2026 -
16:34:33
|
Ask Volume |
|---|---|---|---|---|
|
15.65
+0.07
(
+0.45% )
|
15.65
|
100 |
15.66
|
200 |
Analysis date: 24.04.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 18.11.2025.
Interest
Very strong
Very strong
Four stars since 17.04.2026.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 27.02.2026 at a price of 16.25.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 14.04.2026.
4wk Rel Perf
3.33%
3.33%
The four-week dividend-adjusted overperformance versus SP500 is 3.33%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 18.11.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.07%.
Mkt Cap in $bn
4.43
4.43
With a market capitalization between $2 & $8bn, SOTERA HEALTH CO. is considered a mid-cap stock.
G/PE Ratio
0.93
0.93
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
13.15
13.15
The estimated PE is for the year 2028.
LT Growth
12.27%
12.27%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
8
8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
173
173
For 1% of index variation, the stock varies on average by 1.73%.
Correlation
0.51
0.51
51.48% of stock movements are explained by index variations.
Value at Risk
3.34
3.34
The value at risk is estimated at USD 3.34. The risk is therefore 21.44%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
26.03.2021
26.03.2021